SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-18-026617
Filing Date
2018-04-27
Accepted
2018-04-27 16:42:00
Documents
1
Period of Report
2017-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4168
  Complete submission text file 0001209191-18-026617.txt   5759
Mailing Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203
Business Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203 716-898-8625
Athenex, Inc. (Issuer) CIK: 0001300699 (see all company filings)

IRS No.: 431985966 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ATHENEX, INC. 1001 MAIN STREET SUITE 600 BUFFALO NY 14203
Business Address
Trainor-Degirolamo Sheldon (Reporting) CIK: 0001708966 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38112 | Film No.: 18784692